BIT
WST icon

BlackRock Institutional Trust’s West Pharmaceutical WST Stock Holding History

BlackRock Institutional Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$185M Sell
2,185,773
-121,479
-5% -$9.55M 0.03% 609
2016
Q3 		$172M Buy
2,307,252
+9,016
+0.4% +$716K 0.03% 612
2016
Q2 		$174M Buy
2,298,236
+253,128
+12% +$18.4M 0.03% 597
2016
Q1 		$142M Buy
2,045,108
+18,518
+0.9% +$1.11M 0.02% 675
2015
Q4 		$122M Buy
2,026,590
+60,338
+3% +$3.63M 0.02% 737
2015
Q3 		$106M Buy
1,966,252
+312,626
+19% +$18.2M 0.02% 794
2015
Q2 		$96M Sell
1,653,626
-93,005
-5% -$5.19M 0.02% 910
2015
Q1 		$105M Buy
1,746,631
+57,506
+3% +$3.06M 0.02% 895
2014
Q4 		$89.9M Sell
1,689,125
-52,968
-3% -$2.65M 0.01% 942
2014
Q3 		$78M Sell
1,742,093
-133,184
-7% -$5.66M 0.01% 992
2014
Q2 		$79.1M Sell
1,875,277
-130,178
-6% -$5.57M 0.01% 1027
2014
Q1 		$88.3M Buy
2,005,455
+182,461
+10% +$8.59M 0.02% 943
2013
Q4 		$89.4M Sell
1,822,994
-50,869
-3% -$2.38M 0.02% 912
2013
Q3 		$77.1M Sell
1,873,863
-7,219
-0.4% -$275K 0.01% 936
2013
Q2 		$66.1M Buy
+1,881,082
New +$61.9M 0.01% 975

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BlackRock Institutional Trust's WST Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its West Pharmaceutical (WST) stake by 5.3% in Q4 2016, selling an estimated $9.55M and leaving 2,185,773 shares worth $185M. The position accounts for 0.03% of the portfolio, ranked #609.

BlackRock Institutional Trust first reported a position in WST in Q2 2013 and has held it in 15 quarters since. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

  • BlackRock Institutional Trust held 2,185,773 shares of West Pharmaceutical worth $185M as of Q4 2016.
  • BlackRock Institutional Trust sold 121,479 West Pharmaceutical shares in Q4 2016, an estimated $9.55M.
  • West Pharmaceutical made up 0.03% of BlackRock Institutional Trust's portfolio in Q4 2016, its #609 holding.
  • BlackRock Institutional Trust first reported a position in West Pharmaceutical in Q2 2013 and has held it in 15 quarters since.
  • 288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.